Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bayesian optimized propofol target-controlled infusion
NL-OMON40537Phase 4Active, not recruiting
- Sponsor
- Anesthesiologie - Onderzoeksbureau (UMCG)
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol in None, sponsored by Anesthesiologie - Onderzoeksbureau (UMCG). Primary endpoint: Median absolute prediction error. Started May 2014; status: active, not recruiting.
02
Drugs
propofol
Beyond the preview
Go deeper on NL-OMON40537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40537.